|
TELA | Tela Bio, Inc. |
| Surgical & Medical Instruments & Apparatus |
| Book value per $ invested | $ 0.08 |
| Leverage | 97.47% |
| Market Cap | $ 20.2m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -38.9m |
| Margin | -49.81% |
TELA Bio, Inc., a medical technology company, focuses on the design, development and commercialization of tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is headquartered in Malvern, Pennsylvania.